Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Microorganisms in Medicine and Therapeutics

Microorganisms in Medicine and Therapeutics

Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.

Vaccines

Vaccines

Vaccines are among the most effective tools in preventive medicine, designed to prepare the immune system to recognize and combat infectious agents. By introducing antigens—substances that the immune system identifies as foreign—vaccines stimulate an adaptive immune response that leads to immunological memory. This immunological memory enables the body to mount a faster and more effective response upon future exposures to the actual pathogen.Vaccines can be categorized based on the...

Vaccine Production

Vaccine Production

Vaccine production involves a sequence of upstream and downstream processes to generate a safe and effective immunological product. It begins with cultivating microorganisms, such as viruses or bacteria, to obtain antigenic material. For viral vaccines, mammalian host cells are grown in bioreactors and subsequently infected with the target virus. The virus replicates within the host cells, which are lysed to release viral particles. This lysate is then clarified through filtration or...

Vaccinations

Vaccinations

Introduction to Virus

Introduction to Virus

Viruses are unique biological entities that blur the boundary between living and non-living systems. Although they lack cellular structure and metabolic processes, they can exhibit characteristics of life when infecting a host. Their defining feature is a nucleic acid core, composed of either DNA or RNA, encapsulated within a protein coat called a capsid. This simple structure allows them to invade host cells and use their machinery for replication efficiently.Viral Structure and...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Pioneering plant virology research for a healthier future: a summary of the 2025 American Society for Virology (ASV) Plant Virology Satellite Symposium.

Journal of virology·2026

Same author

Streamlined molecular farming of plant virus therapeutics for space flight and other low-resource environments.

NPJ science of plants·2026

Same author

Cowpea mosaic virus as a candidate for intratumoral immunotherapy: progress, challenges, and future directions.

Advanced drug delivery reviews·2026

Same author

A strong, reversible, and conformal adhesive gel for diverse plants.

Science advances·2026

Same author

Comparative analyses for plant virus-based cancer immunotherapy drug development.

Cell biomaterials·2026

Same author

Plant-Produced Viral Nanoparticles Decorated with Nanobodies Against HER2 Improve Retention and Recruitment of Immune Cells in Solid Tumors.

Advanced healthcare materials·2026

Search research articles

Related Experiment Video

Updated: Mar 27, 2026

Synthesis and Characterization of mRNA-Loaded PolyBeta Aminoesters Nanoparticles for Vaccination Purposes

Synthesis and Characterization of mRNA-Loaded PolyBeta Aminoesters Nanoparticles for Vaccination Purposes

Published on: August 13, 2021

Virus-based nanoparticles as platform technologies for modern vaccines.

Karin L Lee¹, Richard M Twyman², Steven Fiering³

¹Department of Biomedical Engineering, Case Western Reserve University Schools of Engineering and Medicine, Cleveland, OH, USA.

Wiley Interdisciplinary Reviews. Nanomedicine and Nanobiotechnology

|January 20, 2016

Summary

Virus-based nanoparticles are revolutionizing vaccine and immunotherapy development. These engineered viral nanoscaffolds offer a versatile platform for preventing and treating diseases, including cancer and addiction.

More Related Videos

A "Plug-And-Display" Nanoparticle Vaccine Platform Based on Outer Membrane Vesicles Displaying SARS-CoV-2 Receptor-Binding Domain

A "Plug-And-Display" Nanoparticle Vaccine Platform Based on Outer Membrane Vesicles Displaying SARS-CoV-2 Receptor-Binding Domain

Published on: July 25, 2022

Production of E. coli-expressed Self-Assembling Protein Nanoparticles for Vaccines Requiring Trimeric Epitope Presentation

Production of E. coli-expressed Self-Assembling Protein Nanoparticles for Vaccines Requiring Trimeric Epitope Presentation

Published on: August 21, 2019

Related Experiment Videos

Last Updated: Mar 27, 2026

Synthesis and Characterization of mRNA-Loaded PolyBeta Aminoesters Nanoparticles for Vaccination Purposes

Synthesis and Characterization of mRNA-Loaded PolyBeta Aminoesters Nanoparticles for Vaccination Purposes

Published on: August 13, 2021

A "Plug-And-Display" Nanoparticle Vaccine Platform Based on Outer Membrane Vesicles Displaying SARS-CoV-2 Receptor-Binding Domain

A "Plug-And-Display" Nanoparticle Vaccine Platform Based on Outer Membrane Vesicles Displaying SARS-CoV-2 Receptor-Binding Domain

Published on: July 25, 2022

Production of E. coli-expressed Self-Assembling Protein Nanoparticles for Vaccines Requiring Trimeric Epitope Presentation

Production of E. coli-expressed Self-Assembling Protein Nanoparticles for Vaccines Requiring Trimeric Epitope Presentation

Published on: August 21, 2019

Area of Science:

Nanomedicine and Nanobiotechnology
Immunology
Virology

Background:

Nanoscale engineering is transforming vaccine and immunotherapy development.
Viruses serve as adaptable nanoscaffolds due to their unique properties and immunogenicity.
Viral surface antigens can be engineered for targeted therapeutic applications.

Purpose of the Study:

To review the development of virus-based nanoparticle systems for vaccines.
To explore applications in infectious diseases, chronic diseases, cancer, and addiction.

Main Methods:

Focus on engineered viral nanoparticles as vaccine platforms.
Review of immunogenic properties and antigen display strategies.
Analysis of applications in disease prevention and treatment.

Main Results:

Virus-based nanoparticles show promise as versatile vaccine candidates.
Applications span infectious diseases, chronic conditions, cancer, and addiction.
Engineered viral structures offer targeted immune responses.

Conclusions:

Virus-based nanoparticles represent a significant advancement in vaccine and immunotherapy design.
Their adaptability and immunogenicity make them valuable tools for diverse medical applications.
Further development holds potential for novel treatments against various diseases.